Engineering and targeting potential of CAR NK cells in colorectal cancer
Abstract. Colorectal cancer (CRC), a major global health concern, necessitates innovative treatments. Chimeric antigen receptor (CAR) T cells have shown promises, yet they grapple with challenges. The spotlight pivots to the rising heroes: CAR natural killer (NK) cells, offering advantages such as h...
Saved in:
| Main Authors: | Muhammad Babar Khawar, Ali Afzal, Shuangshuang Dong, Yue Si, Haibo Sun, Yuanyuan Ji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-07-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003346 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel strategies to overcome tumor immunotherapy resistance using CAR NK cells
by: Jun-Hui Guo, et al.
Published: (2025-05-01) -
Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease
by: Ali Afzal, et al.
Published: (2025-01-01) -
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
by: Erica Torchiaro, et al.
Published: (2024-12-01) -
Application and prospects of genetic engineering in CAR-NK cell therapy
by: Caidong Hu, et al.
Published: (2025-05-01) -
Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma.
by: Lei Yang, et al.
Published: (2025-01-01)